Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3
- 205 Downloads
To demonstrate that arsenic trioxide (As2O3) induces apoptosis via a mitochondrial pathway in both parent T lymphoblastoid leukemia MOLT-4 cells and cells of its daunorubicin-resistant subline, MOLT-4/DNR, expressing functional P-gp.
Cell growth was measured using an MTT assay. Cell viability was determined using a dye exclusion test. Intracellular glutathione (GSH) was measured using a glutathione assay kit. Mitochondrial membrane potential (MMP) was assessed by rhodamine 123 (Rh123) staining intensity on flow cytometry. Caspase-3 activity was evaluated using a commercially available assay kit on flow cytometry. The percentage of cells undergoing apoptosis was estimated in terms of caspase+/PI− cells on flow cytometry after assessment for activation of caspase-3 by adding PI.
MOLT-4 cells and MOLT-4/DNR cells were similarly sensitive to the apoptosis-inducing effect of As2O3. Buthionine sulfoxide (BSO) and ascorbic acid (AA) rendered these cells more sensitive to As2O3, whereas N-acetylcysteine (NAC) reduced this sensitivity. BSO and AA decreased, but NAC increased, the intracellular GSH contents of both MOLT-4 and MOLT-4/DNR cells. Decreasing GSH with BSO potentiated As2O3-mediated growth inhibition, disruption of MMP, activation of caspase-3 and apoptosis of cells. Clinically relevant doses of AA enhanced the anticancer effects of As2O3 via the disruption of MMP, activation of caspase-3, and induction of apoptosis. In contrast, increase GSH levels with NAC attenuated all of these As2O3-mediated actions.
The sensitivity of MOLT-4 and MOLT-4/DNR cells to As2O3 was associated with the intracellular GSH content. As2O3 induced apoptosis in parent MOLT-4 cells and MOLT-4/DNR cells expressing functional P-gp via depletion of intracellular GSH, and subsequent disruption of MMP and activation of caspase-3.
KeywordsArsenic trioxide Apoptosis Glutathione Mitochondrial membrane potential Caspase-3
- 2.Bachleitner-Hofmann T, Gisslinger B, Grumbeck E, Gisslinger H (2001) Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukemia? Br J Haematol 112:783Google Scholar
- 5.Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88:1052PubMedGoogle Scholar
- 14.Hu XM, Ma L, Hu NP, Wang ZF, Yang L, Li L, Wang ZX, Wang HZ, Wang N, Liu C, Liu F, Yang JM, Ma R (1999) AiLing I (As2O3) in treating 62 cases of acute promyelocytic leukemia (in Chinese). Chin J Integrat Chin West Med 19:473Google Scholar
- 16.Iguchi K, Hirano K, Ishida R (2002) Activation of caspase-3, proteolytic cleavage of DFF and no oligonucleosomal DNA fragmentation in apoptotic molt-4 cells. J Biochem (Tokyo) 131:469Google Scholar
- 17.Jia P, Chen G, Huang X, Cai X, Yang J, Wang L, Zhou Y, Shen Y, Zhou L, Yu Y, Chen S, Zhang X, Wang Z (2001) Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Chin Med J (Engl) 114:19Google Scholar
- 25.Lee TC, Wei ML, Chang WJ, Ho IC, Lo JF, Jan KY, Huang H (1989) Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster ovary cells. In Vitro Dev Biol 25:442Google Scholar
- 45.Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM Q, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:3354PubMedGoogle Scholar
- 47.Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutre S, Dahlberg S, Ellison R, Warrell RP Jr (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19:3852PubMedGoogle Scholar
- 57.Zhang Y, Nie L (2001) Studies of apoptosis of malignant lymphoma cells induced by arsenic trioxide. Cell Biol Int 25:1003Google Scholar